Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Search Results for: label/AGA Medical – Page 3

Johnson & Johnson In $77 Million Global Settlement

[…] in the life sciences industry.” Medical-device makers Biomet Inc., Stryker Corp., Zimmer Holdings Inc., Smith & Nephew plc and Medtronic Inc. disclosed FCPA investigations during 2007; Wright Medical reported a similar investigation in June 2008. The DOJ and SEC both said they reduced Johnson & Johnson’s financial penalties in light of the company’s civil […]

Read More »

An Abundance Of Caution

The Justice Department last week issued its first Foreign Corrupt Practices Act Opinion Procedure Release of the year. The Requestor in Release No. 09-01 is a medical device maker that wants to introduce its product to a foreign government. Unlike its few global competitors, it isn’t well known in the target country. To introduce […]

Read More »

‘Authorizing’ is at the center of most FCPA cases

[…] Beam Suntory (2020), Cognizant (2019), Keppel Offshore & Marine (2017), LAN Airlines (2016), Smith & Wesson (2014), Innospec (2010), Snamprogetti, ENI (2010), Parker Drilling Company (2013), AGA Medical (2008), and so on. If “authorizing” is done corruptly — that is, with some knowledge it might result in a bribe payment — the authorizing person […]

Read More »

China Province Hits Medical Graft

Officials in the southern province of Yunnan announced the approval of regulatory changes designed to stem medical corruption, including the introduction of a blacklist of bribery offenders.

Read More »

Drug sellers ‘take vacations’ amid China anti-graft campaign

[…] will be fined 500 yuan ($81) and regional sales managers 1000 yuan ($162) once being caught in hospitals,” an unidentified sales representative told the paper. Meanwhile, many medical conferences that were to be staged by pharmaceutical companies have been suspended. “Doctors are afraid of being drawn into corruption allegations through participation of medical conferences,” […]

Read More »

A stacked procurement deck drove me out of my job

In the prior post, I published part of a note from an acquaintance in Belarus who used to work in a medical supply firm. It described a centralized, top-down procurement system susceptible to widespread graft. In this post, he talks about specific buying practices that defeat the rule of law, perpetuate the system, and […]

Read More »